Annual total expenses:
$1.68B+$172.74M(+11.43%)Summary
- As of today (May 29, 2025), SRPT annual total expenses is $1.68 billion, with the most recent change of +$172.74 million (+11.43%) on December 31, 2024.
- During the last 3 years, SRPT annual total expenses has risen by +$532.30 million (+46.22%).
- SRPT annual total expenses is now at all-time high.
Performance
SRPT Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$1.05B+$548.51M(+110.42%)Summary
- As of today (May 29, 2025), SRPT quarterly total expenses is $1.05 billion, with the most recent change of +$548.51 million (+110.42%) on March 1, 2025.
- Over the past year, SRPT quarterly total expenses has increased by +$666.68 million (+176.11%).
- SRPT quarterly total expenses is now at all-time high.
Performance
SRPT Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
SRPT Total expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +11.4% | +176.1% |
3 y3 years | +46.2% | +251.1% |
5 y5 years | +86.5% | +351.1% |
SRPT Total expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +46.2% | at high | +251.1% |
5 y | 5-year | at high | +86.5% | at high | +366.9% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
SRPT Total expenses History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $1.05B(+110.4%) |
Dec 2024 | $1.68B(+11.4%) | $496.73M(+11.6%) |
Sep 2024 | - | $444.98M(+22.4%) |
Jun 2024 | - | $363.63M(-3.9%) |
Mar 2024 | - | $378.56M(+1.7%) |
Dec 2023 | $1.51B(+2.9%) | $372.16M(+5.5%) |
Sep 2023 | - | $352.66M(-10.7%) |
Jun 2023 | - | $394.76M(+0.8%) |
Mar 2023 | - | $391.59M(+7.2%) |
Dec 2022 | $1.47B(+27.6%) | $365.26M(+1.0%) |
Sep 2022 | - | $361.62M(-18.7%) |
Jun 2022 | - | $444.62M(+49.3%) |
Mar 2022 | - | $297.71M(-3.1%) |
Dec 2021 | $1.15B(+4.3%) | $307.27M(+37.3%) |
Sep 2021 | - | $223.86M(-32.5%) |
Jun 2021 | - | $331.66M(+14.8%) |
Mar 2021 | - | $288.80M(-8.6%) |
Dec 2020 | $1.10B(+22.3%) | $315.85M(+12.4%) |
Sep 2020 | - | $280.99M(+1.9%) |
Jun 2020 | - | $275.72M(+19.0%) |
Mar 2020 | - | $231.70M(-27.7%) |
Dec 2019 | $903.16M(+40.1%) | $320.33M(+43.9%) |
Sep 2019 | - | $222.63M(+13.1%) |
Jun 2019 | - | $196.79M(+20.4%) |
Mar 2019 | - | $163.40M(-26.2%) |
Dec 2018 | $644.66M(+116.5%) | $221.56M(+49.1%) |
Sep 2018 | - | $148.59M(-17.1%) |
Jun 2018 | - | $179.18M(+87.9%) |
Mar 2018 | - | $95.34M(+14.9%) |
Dec 2017 | $297.80M(+10.5%) | $83.01M(+25.3%) |
Sep 2017 | - | $66.27M(-28.8%) |
Jun 2017 | - | $93.09M(+67.5%) |
Mar 2017 | - | $55.59M(-39.5%) |
Dec 2016 | $269.60M(+21.8%) | $91.91M(+62.6%) |
Sep 2016 | - | $56.53M(-8.8%) |
Jun 2016 | - | $61.98M(+3.8%) |
Mar 2016 | - | $59.70M(-9.1%) |
Dec 2015 | $221.44M(+54.3%) | $65.70M(+26.9%) |
Sep 2015 | - | $51.76M(+22.9%) |
Jun 2015 | - | $42.11M(-31.9%) |
Mar 2015 | - | $61.86M(+38.2%) |
Dec 2014 | $143.55M(+37.4%) | $44.75M(+28.8%) |
Sep 2014 | - | $34.73M(+5.7%) |
Jun 2014 | - | $32.85M(+5.3%) |
Mar 2014 | - | $31.21M(-12.0%) |
Dec 2013 | $104.50M(+55.9%) | $35.48M(+21.9%) |
Sep 2013 | - | $29.10M(+45.2%) |
Jun 2013 | - | $20.04M(+0.7%) |
Mar 2013 | - | $19.89M(+12.3%) |
Dec 2012 | $67.03M(-19.2%) | $17.70M(+22.3%) |
Sep 2012 | - | $14.48M(-13.6%) |
Jun 2012 | - | $16.76M(-7.3%) |
Mar 2012 | - | $18.09M(-19.9%) |
Dec 2011 | $82.92M(+64.7%) | $22.59M(+20.2%) |
Sep 2011 | - | $18.80M(-13.4%) |
Jun 2011 | - | $21.71M(+9.5%) |
Mar 2011 | - | $19.83M(+14.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | $50.35M(+52.2%) | $17.26M(+38.1%) |
Sep 2010 | - | $12.50M(+7.2%) |
Jun 2010 | - | $11.66M(+30.5%) |
Mar 2010 | - | $8.94M(-1.7%) |
Dec 2009 | $33.09M(-14.7%) | $9.10M(-1.9%) |
Sep 2009 | - | $9.27M(+15.8%) |
Jun 2009 | - | $8.01M(+19.3%) |
Mar 2009 | - | $6.71M(-19.8%) |
Dec 2008 | $38.80M(-12.0%) | $8.37M(-24.6%) |
Sep 2008 | - | $11.11M(+12.6%) |
Jun 2008 | - | $9.86M(+4.3%) |
Mar 2008 | - | $9.46M(-12.9%) |
Dec 2007 | $44.09M(+33.2%) | $10.85M(-5.0%) |
Sep 2007 | - | $11.43M(+2.1%) |
Jun 2007 | - | $11.19M(+5.4%) |
Mar 2007 | - | $10.62M(+20.8%) |
Dec 2006 | $33.10M(+48.4%) | $8.79M(+20.6%) |
Sep 2006 | - | $7.29M(-2.0%) |
Jun 2006 | - | $7.44M(-22.4%) |
Mar 2006 | - | $9.59M(+51.6%) |
Dec 2005 | $22.30M(-12.5%) | $6.32M(+21.6%) |
Sep 2005 | - | $5.20M(+0.2%) |
Jun 2005 | - | $5.19M(-7.2%) |
Mar 2005 | - | $5.59M(+7.0%) |
Dec 2004 | $25.47M(+28.4%) | $5.22M(+1.8%) |
Sep 2004 | - | $5.13M(-29.4%) |
Jun 2004 | - | $7.27M(-7.4%) |
Mar 2004 | - | $7.85M(+7.7%) |
Dec 2003 | $19.84M(-24.2%) | $7.29M(+43.2%) |
Sep 2003 | - | $5.09M(+37.1%) |
Jun 2003 | - | $3.72M(-0.6%) |
Mar 2003 | - | $3.74M(-13.5%) |
Dec 2002 | $26.18M(+62.5%) | $4.32M(-22.9%) |
Sep 2002 | - | $5.60M(-31.0%) |
Jun 2002 | - | $8.12M(-0.2%) |
Mar 2002 | - | $8.13M(+61.8%) |
Dec 2001 | $16.11M(+39.6%) | $5.03M(+37.6%) |
Sep 2001 | - | $3.65M(-5.7%) |
Jun 2001 | - | $3.87M(+8.9%) |
Mar 2001 | - | $3.56M(+2.2%) |
Dec 2000 | $11.54M(+37.4%) | $3.48M(+28.2%) |
Sep 2000 | - | $2.71M(-8.8%) |
Jun 2000 | - | $2.97M(+25.4%) |
Mar 2000 | - | $2.37M(-1.1%) |
Dec 1999 | $8.40M(+6.3%) | $2.40M(+9.1%) |
Sep 1999 | - | $2.20M(+10.0%) |
Jun 1999 | - | $2.00M(+17.6%) |
Mar 1999 | - | $1.70M(-34.6%) |
Dec 1998 | $7.90M(+97.5%) | $2.60M(+36.8%) |
Sep 1998 | - | $1.90M(+5.6%) |
Jun 1998 | - | $1.80M(+12.5%) |
Mar 1998 | - | $1.60M(+60.0%) |
Dec 1997 | $4.00M(+73.9%) | $1.00M(0.0%) |
Sep 1997 | - | $1.00M(-23.1%) |
Jun 1997 | - | $1.30M(+85.7%) |
Mar 1997 | - | $700.00K |
Dec 1996 | $2.30M | - |
FAQ
- What is Sarepta Therapeutics annual total expenses?
- What is the all time high annual total expenses for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual total expenses year-on-year change?
- What is Sarepta Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly total expenses year-on-year change?
What is Sarepta Therapeutics annual total expenses?
The current annual total expenses of SRPT is $1.68B
What is the all time high annual total expenses for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual total expenses is $1.68B
What is Sarepta Therapeutics annual total expenses year-on-year change?
Over the past year, SRPT annual total expenses has changed by +$172.74M (+11.43%)
What is Sarepta Therapeutics quarterly total expenses?
The current quarterly total expenses of SRPT is $1.05B
What is the all time high quarterly total expenses for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly total expenses is $1.05B
What is Sarepta Therapeutics quarterly total expenses year-on-year change?
Over the past year, SRPT quarterly total expenses has changed by +$666.68M (+176.11%)